Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise
- 1 April 1994
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (9), 647-652
- https://doi.org/10.1016/0002-9149(94)90927-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Prognostic value of dipyridamole thallium-201 imaging in elderly patientsJournal of the American College of Cardiology, 1992
- Usefulness of single-photon emission computed tomography of thallium-201 uptake after dipyridamole infusion for detection of coronary artery diseaseThe American Journal of Cardiology, 1992
- Prognostic value of dipyridamole thallium-201 scintigraphy in patients with stable chest painAmerican Heart Journal, 1992
- Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.Circulation, 1991
- Technetium-99m sestamibi in chronic coronary artery disease: The european experienceThe American Journal of Cardiology, 1990
- Technetium-99m sestamibi myocardial imaging: Same-day rest-stress studies and dipyridamoleThe American Journal of Cardiology, 1990
- Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart diseaseJournal of the American College of Cardiology, 1990
- Evaluation of coronary artery disease in the patient unable to exercise: Alternatives to exercise stress testingAmerican Heart Journal, 1989
- Tomographic thallium-201 myocardial perfusion scintigrams after maximal coronary artery vasodilation with intravenous dipyridamole. Comparison of qualitative and quantitative approaches.Circulation, 1982
- Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trialThe American Journal of Cardiology, 1978